Coordnted Care HLTH Sltons LLC

Established in 1929, Allergy Laboratories Inc. is a Food and Drug Administration (FDA) licensed pharmaceutical manufacturer of over 500 different biological extracts for the diagnostic testing and therapeutic treatment of allergies. Based in Oklahoma City, Okla., it offers the necessary supplies to support the practice of immunotherapy. The company also provides sterile depyrogenated vials/diluents providing products, including bulk and diagnostic extracts, sterile empty vials, controls, supplies, diluents, custom mixes and dropper vials. Allergy Laboratories Inc. also provides a number of services, such as cGMP manufacturing, quality-assurance, raw materials and safety testing, among others.

Diagnostic Laboratory of Oklahoma, also known as DLO, offers a range of clinical laboratory testing services for physicians, hospitals and clinics throughout Oklahoma. It manages more than 20 patient service centers and serves over 2,000 physician offices and hospitals on a daily basis. The laboratory is certified to perform examinations in various specialties, such as bacteriology, mycobacteriology, mycology, virology, syphilis serology, general immunology, routine chemistry, urinalysis, endocrinology, toxicology and hematology. Diagnostic Laboratory of Oklahoma oversees a professional staff of nearly 750 employees. It is accredited by the College of American Pathologists (CAP) and the Department of Health and Human Services. Diagnostic Laboratory of Oklahoma is located in Oklahoma City, Okla.

Biolytx Pharmaceuticals is an emerging drug development company based in Oklahoma City, Oklahoma, dedicated to addressing the crisis of antibiotic drug resistance. Specializing in the advancement of antimicrobial peptide drug candidates, Biolytx focuses on treating serious pathogens that currently lack effective therapeutic options. With a core technology centered around developing novel antibiotic peptides for combating hospital-acquired infections, including those resistant to existing antibiotics, Biolytx aims to progress its pipeline to facilitate collaborations with pharmaceutical companies for clinical trials. Led by CEO Doug Branch, the company's innovative approach targets drug-resistant bacteria, offering potential solutions to critical healthcare challenges.Generated from the website